dc.contributor.author | Teis, Albert | |
dc.contributor.author | Cediel, G. | |
dc.contributor.author | Amigó, Núria | |
dc.contributor.author | Julve, Josep | |
dc.contributor.author | Aranyó, J. | |
dc.contributor.author | Andrés‑Cordón, J. | |
dc.contributor.author | Puig‑Jové, C. | |
dc.contributor.author | Castelblanco Echavarría, Esmeralda | |
dc.contributor.author | Gual‑Capllonch, F. | |
dc.contributor.author | Ferrer‑Sistach, E. | |
dc.contributor.author | Vallejo, N. | |
dc.contributor.author | Juncà, G. | |
dc.contributor.author | López‑Ayerbe, J. | |
dc.contributor.author | De Antonio, M. | |
dc.contributor.author | Domingo, M. | |
dc.contributor.author | Santiago‑Vacas, E. | |
dc.contributor.author | Codina, P. | |
dc.contributor.author | Mauricio Puente, Dídac | |
dc.contributor.author | Lupón, J. | |
dc.contributor.author | Alonso, Núria | |
dc.contributor.author | Bayes‑Genis, A. | |
dc.date.accessioned | 2021-10-26T10:09:46Z | |
dc.date.available | 2021-10-26T10:09:46Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 2045-2322 | |
dc.identifier.uri | http://hdl.handle.net/10459.1/72143 | |
dc.description.abstract | Evidence regarding any association of HDL-particle (HDL-P) derangements and HDL-cholesterol content with cardiovascular (CV) death in chronic heart failure (HF) is lacking. To investigate the prognostic value of HDL-P size (HDL-Sz) and the number of cholesterol molecules per HDL-P for CV death in HF patients. Outpatient chronic HF patients were enrolled. Baseline HDL-P number, subfractions and HDL-Sz were measured using 1H-NMR spectroscopy. The HDL-C/P ratio was calculated as HDL-cholesterol over HDL-P. Endpoint was CV death, with non-CV death as the competing event. 422 patients were included and followed-up during a median of 4.1 (0–8) years. CV death occurred in 120 (30.5%) patients. Mean HDL-Sz was higher in CV dead as compared with survivors (8.39 nm vs. 8.31 nm, p < 0.001). This change in size was due to a reduction in the percentage of small HDL-P (54.6% vs. 60% for CV-death vs. alive; p < 0.001). HDL-C/P ratio was higher in the CV-death group (51.0 vs. 48.3, p < 0.001). HDL-Sz and HDL-C/P ratio were significantly associated with CV death after multivariable regression analysis (HR 1.22 [95% CI 1.01–1.47], p = 0.041 and HR 1.04 [95% CI 1.01–1.07], p = 0.008 respectively). HDL-Sz and HDL-C/P ratio are independent predictors of CV death in chronic HF patients. | ca_ES |
dc.description.sponsorship | Tis work was supported by Grants from Fundació La MARATÓ de TV3 (201502 and 201516 to AB-G, 201602- 30-31 to NA and JJ), Ministerio de Educación y Ciencia (SAF2014-59892 to AB-G), AdvanceCat (2014-2020 to AB-G), Ministerio de Economía y Competitividad (MINECO)—Instituto de Salud Carlos III (ISCIII) (PI17- 00232 to JJ, PI17-01362 to NA, PI15-00625 to DM, and RED2018-102799-T to JJ), and by CIBER on Cardiovascular Diseases (CIBERCV, CB16/11/00403) and CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM, CB15/00071 and CB07/08/0016) are an initiative from ISCIII, Spain with co-funding from the European Regional Development Fund (ERDF). JJ is supported by funds provided by ISCIII (Grant CPII18/00004, Miguel Servet II program). | ca_ES |
dc.language.iso | eng | ca_ES |
dc.publisher | Nature Portfolio | ca_ES |
dc.relation.isformatof | Reproducció del document publicat a https://doi.org/10.1038/s41598-021-82861-6 | ca_ES |
dc.relation.ispartof | Scientific Reports, 2021, vol. 11, 3141 | ca_ES |
dc.rights | cc-by (c) Teis et al., 2021 | ca_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.title | Particle size and cholesterol content of circulating HDL correlate with cardiovascular death in chronic heart failure | ca_ES |
dc.type | info:eu-repo/semantics/article | ca_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | ca_ES |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca_ES |
dc.identifier.doi | https://doi.org/10.1038/s41598-021-82861-6 | |